Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01495494 · ClinicalTrials.gov registry record · Phase 1
A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01495494 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 80 participants.
The verdict
NCT01495494, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study evaluated the safety \& tolerability of two Breathe Right nasal strip prototypes. Prototypes were produced as an improvement to the currently marketed product.
Interventions
- DEVICE Marketed Nasal Strip
- DEVICE Prototype Nasal Dilator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-11 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01495494
The ClinicalTrials.gov registry entry for NCT01495494 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Marketed Nasal Strip is the first listed.
NCT01495494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01495494 about?
NCT01495494 is a clinical study titled "A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype". This study evaluated the safety \& tolerability of two Breathe Right nasal strip prototypes. Prototypes were produced as an improvement to the currently marketed product.
What is the current status of trial NCT01495494?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2009-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01495494?
The interventions under investigation include: Marketed Nasal Strip (DEVICE), Prototype Nasal Dilator (DEVICE).
Who is sponsoring clinical trial NCT01495494?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.